Skip to main content

Logo 202 Logo 202 (Methylphenidate Hydrochloride Extended-Release (LA) 40 mg)

Pill with imprint Logo 202 Logo 202 is Blue & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 40 mg. It is supplied by Mayne Pharma.

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo 202 Logo 202

Methylphenidate Hydrochloride Extended-Release (LA)

Logo 202 Logo 202
40 mg
Blue & White
19.00 mm
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Mayne Pharma
Catalent Pharma Solutions, LLC
National Drug Code (NDC)
51862-0265 (Discontinued)
Inactive Ingredients
sucrose, corn starch, cellulose acetate, hypromellose acetate succinate 12070923 (3 mm2/s), acetyltributyl citrate, acetone, magnesium silicate, water, titanium dioxide, ferrosoferric oxide, shellac, potassium hydroxide, FD&C Blue No. 1, D&C Red No. 28

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.